No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Specialties
Based in Wonju, South Korea, JETEMA, Co., Ltd. is a dynamic bio-venture firm dedicated to the innovation and development of pharmaceuticals and medical technologies. Their comprehensive portfolio encompasses a range of advanced solutions, including aesthetic treatments such as botulinum toxins, dermal fillers, and specialized anti-aging remedies, along with medical lifting threads. Additionally, they provide laser surgical instruments and hyaluronic acid masks for skincare.
www.jetema.comNo one on the platform currently holds 216080.KQ.
No tracked institution reports a position in 216080.KQ as of their last filing.
No one on the platform has traded 216080.KQ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | 12.2% | 30.1% | ||||
| Profit Margin % | -8.6% | 10.2% | ||||
| Free Cash Flow Margin % | 7.0% | -27.9% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $90.0B | +19.5% | $47.00 | $47.00–$47.00 | — | 1 |
| 2027 | $109.7B | +21.9% | $154.00 | $154.00–$154.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 216080.KQJETEMA, Co., Ltd. | $7190.00 | -0.83% | $267.5B | — |
| 011000.KSGeneOne Life Science, Inc. | $2670.00 | -7.45% | $48.4B | — |
| 038290.KQMacrogen, Inc. | $11750.00 | -0.42% | $127.4B | — |
| 065660.KQAnterogen.Co.,Ltd. | $15230.00 | +1.94% | $152.4B | — |
| 084990.KQHelixmith Co., Ltd | $2935.00 | +0.51% | $135.1B | — |
| 092040.KQAmicogen, Inc. | $833.00 | +1.34% | $47.4B | — |
| 095700.KQGenexine, Inc. | $2805.00 | +0.54% | $127.6B | — |
Source: Financial Modeling Prep · peers by sector/industry